Home » Nektar Says Pain Drug Gets Fast Track FDA Status
Nektar Says Pain Drug Gets Fast Track FDA Status
Nektar Therapeutics said that regulators are giving fast track status to an experimental pain drug the company is developing.
Businessweek
Businessweek
Upcoming Events
-
07May
-
14May
-
30May